CIDRAP newsletters options
A growing number of vaccine makers are expressing concerns about their ability to quickly develop new vaccine candidates against emerging disease threat, such as Zika and Ebola viruses, Stat reported today, based on interviews with pharmaceutical executives, government officials, and infectious disease experts.
The therapy, which uses cattle antibodies to treat the virus in humans, has shown to be safe and well-tolerated.
A study shows avian flu virus detections rising in poultry in Cambodian live-bird markets.
Since 2016 the CDC has provided $144 million to state and local health departments to address antibiotic resistance.
A study yesterday by experts from the US Centers for Disease Control and Prevention (CDC) found that the incidence of Clostridium difficile in long-term care facilities decreased 17.5% annually from 2011 to 2015 at 10 US sites, along with a concomitant decline in inpatient fluoroquinolone use.
About 11% of a population sampled in the Democratic Republic of the Congo (DRC) had Zaire Ebola virus (EBOV) immunoglobulin G antibodies, providing serological evidence of Ebola prevalence in populations not currently experiencing an Ebola outbreak.
No conclusions about potential impacts on human health can be drawn from the study.
The Trump administration is making no effort to prioritize game-changing flu vaccines, the experts say.
Yesterday and today the Saudi Arabian Ministry of Health (MOH) announced four new cases of MERS-CoV in different cities across the country, including one involving a health worker.
It is Iraq's first H5N8 outbreak since 2016, and Afghanistan's first since 2007.
A case-control study by German investigators has found that nosocomial infections caused by vancomycin-resistant enterococci (VRE) are costlier than those caused by vancomycin-susceptible enterococci (VSE), according to a new study in Antimicrobial Resistance & Infection Control.
The Saudi Arabian Ministry of Health (MOH) recorded two new cases of MERS-CoV in Riyadh in recent days.
On Jan 5, a 48-year-old Saudi man from the country's capital was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) after presenting with symptoms. He is in stable condition. The MOH said the man had direct contact with camels, a known risk factor for MERS-CoV.
Two groups gauge the threat of H5N6 avian flu to mammals and poultry.
The H3N2 strain, which often causes more severe seasons, continues to predominate.
The Defense Threat Reduction Agency, a division of the US Department of Defense, has awarded up to $16 million to VenatoRx Pharmaceuticals for discovery and development of a novel, first-in-class antibiotic for biodefense applications.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The Food and Drug Administration (FDA) yesterday announced that, for now, it won't enforce four rules related to the implementation of the Food Safety Modernization Act (FSMA), a law passed in 2011 that signaled the biggest overhaul in the nation's food safety laws in 70 years.
Environment samples tested positive for the "nightmare bacteria," indicating a possible role of cleaning equipment.
A CDC official says though cases are still being reported, the pace of new reports appears to be slowing.
Health officials in Los Angeles County today announced the area's first sexually transmitted Zika case, which involves a male resident who traveled to Mexico and had Zika symptoms in early November and his female partner, who did not travel.
